On February 28, many organizations that advocate for cures, therapies, drugs, and critically early diagnosis for the known 7000 plus rare diseases join forces to focus on rare diseases. We support rarediseaseday.org and the many
From Jorge D. Faccinetti – co-founder. With a pituitary disease like acromegaly, Cushing’s, hypopituitarism, and others, or for that matter, any other chronic condition, a big part of the battle is to get up every
A presentation from Lewis Blevins, M.D. Pituitary World News cofounder and Medical Director of the California Center for Pituitary Disorders at UCSF on the emerging clinical insights of hypercortisolism. Click here to view the presentation.
From the desk of Jorge D Faccinetti, Chairman and chief editor – On April 28, the leading orphan drug industry, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers will meet virtually
Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients’ access to healthcare. Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine. Dr. Blevins shares the findings
Joining a new drug trial, for example, is an action that can benefit many affected with a disease, particularly with a rare disease, where finding enough people for an adequate sample is very challenging.
If you’d like to learn more about Addison’s disease, here’s a perfect opportunity to do so. The Advanced Practice in Endocrinology Nursing is a comprehensive resource on Adrenal Insufficiency and three chapters from the book are
From J D Faccinetti – co-founder – One of the unforeseen consequences of this crisis is how it has affected our editorial decisions, that is, deciding what to write and when to publish. The media
From the desk of J D Faccinetti Chairman, CEO and chief editor Pituitary World News. We recently published two COVID-19 related articles that focused on subjects that are very much in everyone’s mind. One was
At the risk of adding to the Coronavirus news frenzy we’re experiencing, I thought this piece from Gil Bashe, a health communication writer, deserved to be noted. His article points to the substandard job the health
A commentary from Dr. Lewis S Blevins Jr. co-founder – I was recently asked if I felt that we would ever be able to use stem cells to regenerate the pituitary gland. Frankly, the answer is
Today’s podcast is about silent Corticotropic adenomas and the recurrence rate of these tumors vs. all pituitary adenomas. Dr. Blevins weighs into a recent paper as well as current research to discuss why adenomas recur and